Oxidized lipids

Italian Heart Journal

Volumn 2, Issue 12, 2001, Pages 873-877

  Patrignani, Paola ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cyclooxygenase 2; Glyceryl prostaglandins; Isoprostanes; Myocardial infarction; Platelet activating factor like lipids; Prostanoids

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ARACHIDONIC ACID; CYCLOOXYGENASE 2; ISOPROSTANE DERIVATIVE; LIPID; OXYGEN; PHOSPHATIDYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL TONE; CELL COMMUNICATION; CELL METABOLISM; CELL STRUCTURE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORONARY RISK; DISEASE MARKER; GENE MUTATION; GENETIC CODE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPID OXIDATION; MITOGENICITY; PATHOGENESIS; PREDICTION; REGULATORY MECHANISM; RISK ASSESSMENT; VASCULAR ENDOTHELIUM;

HUMANS; LIPID PEROXIDATION; MYOCARDIAL INFARCTION;

EID: 0035571252     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. A thematic series on oxidation of lipids as a source of messengers
2. Atherosclerosis - An inflammatory disease
3. Arachidonic acid oxygenation by COX-1 and COX-2: Mechanisms of catalysis and inhibition
4. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate
5. Is there a role for 15-lipoxygenase in atherogenesis?
6. The coxibs: Rationally designed inhibitors of cyclooxygenase-2
7. COX-2 is not involved in thromboxane biosynthesis by activated human platelets
8. Platelet-active drugs: The relationships among dose, effectiveness, and side effects
9. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
10. 2 in mitogenesis of vascular smooth muscle cells
11. Is cyclooxygenase-2 the alpha and the omega in cancer?
12. COX-1 and COX-2 tissue expression: Implications and predictions
13. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
14. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina
15. COX-2 inhibitors
16. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
17. Adrenocorticotropic hormone; Adrenocortical steroids and their synthetic analogs; Inhibitors and actions of adrenocortical hormones
18. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages
19. Drug addiction and drug abuse
20. Endocannabinoids and vascular function
21. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
22. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase free radical-catalyzed mechanism
23. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease
24. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo
25. 2-isoprostanes in human atherosclerotic lesions
26. Nomenclature of isoprostanes: A proposal
27. 2 receptor in vivo
28. 2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo
29. 2-isoprostane levels are increased in Alzheimer's disease
30. 2α-III, an index of oxidant stress
31. In vivo lipid peroxidation and platelet activation in cystic fibrosis
32. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina
33. 2α is increased in hypercholesterolemia
34. 2α and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation
35. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage
36. Modulation of oxidant stress in vivo in chronic cigarette smokers
37. Increased circulating products of lipid peroxidation in patients with alcoholic liver disease
38. 2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers
39. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice
40. Platelet-activating factor
41. Biologically active oxidized phospholipids